medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2009, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2009; 54 (4)

Uterine myomatosis

Ortiz RME, Matute LÁ, Martínez-Consuegra N

Language: Spanish
References: 37
Page: 222-233
PDF size: 151.28 Kb.


ABSTRACT

Uterine myomas are the most common benign pelvic tumors in women. There is evidence that they have a genetic basis and that its growth is linked to genetic predisposition, hormonal influences, and several growth factors. We currently have a lot of options that include pharmacological management, surgical and radiological intervention. The aim of this article is to review the available literature on the uterine myomatosis.


REFERENCES

  1. Stewart EA. Uterine fibroids. Lancet 2001; 357-389.

  2. Gary NF et al. Myomas and myomectomy. J Minim Invas Gynecol 2005; 12: 443-456.

  3. Edward E. Wallach, MD, and Nikos F. Vlahos, MD. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol 2004; 104 (2): 393-404.

  4. Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 1994; 79: 900-906.

  5. Rein MJ, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Mortin CC. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77: 923-926.

  6. Ligon AH, Mortin CC. Genetics of uterine leiomyomata. Genes Chromosomes Cancer 2000; 28: 235-245.

  7. Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 1985; 4: 89-96.

  8. Nassera S. Banu, Isaac T. Manyonda. Myometrial tumors. Curr Obstet Gynecol 2004; 14: 327-336.

  9. Marshall Lm. Spiegelman D, Barbieri RL et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997; 90: 967-973.

  10. Parazzini F, Negri E, La Vecchia C, Fedele L, Rabaiotti M, Luchini L. Contraceptive use and the risk of uterine fibroids. Obstet Gynecol 1992; 79:430-433.

  11. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande Jt. Risk Factors for uterine fibroids: Reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 1986; 293: 359-362.

  12. Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine leiomyomata. Nutrition 1991; 7: 251-255.

  13. Chiaffarino F,Parazzini F, La Vecchia C, Chatenound L, Di Cintio E, Marsico S. Diet and uterine myomas. Obstet Gynecol 1999; 94: 395-398.

  14. Wyshak G, Frisch RE, Albroght NL, Albright TE, Schiff I. Lower prevalence of benign disease of the breast and benign tumours of the reproductive system among former college athletes compared to nonathletes. Br J Cancer 1986; 54: 841-845.

  15. William H. Parker, MD. Etiology, symptomatology, and diagnosis of uterine myomas. Fertility and Sterility 2007; 87 (4): 725-734.

  16. Rice JP, Kay HH, Mahony BS. The Clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 1989; 160: 1212-1216.

  17. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: A practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153: 11-19.

  18. Stanley J. Robboy, Rex C. Bentley, Kelly Butnor, Malcolm C. Pathology and pathophysiology of uterine smooth-muscle tumors. Environmental Health Perspectives Supplements 2000; 108 (S5).

  19. Cohen DT, Oliva E, Hahn PF, Fuller AF Jr, Lee SI. Uterine Smooth-muscle tumors with unusual growth patterns: Imaging with pathologic correlation. Am J Roentgenol 2007; 188 (1): 246-255.

  20. Kawakami S, Togashi K, Konishi I, Kimura I, Fukuoka M, Mori T, Konishi J. Red degeneration of uterine leiomyoma: MR appearance. J Comput Assist Tomogr 1994; 18 (6): 925-928.

  21. Robboy LS, Anderson M, Russel P. Uterine smooth muscle tumors. In: Pathology of the Female Reproductive Tract. Edimburg: Churchill-Livingstone; 2002. p. 381-402.

  22. Stovall DW. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol 2001; 44: 364-371.

  23. Orhan B, Kevin J. Clinical features of myomas. Obstet Gynecol Clin N Am 2006; 33: 69-84.

  24. Myomas and reproductive function. Fertility and Sterility 2004; 82 (suppl 1): 111-116.

  25. Phelan JP. Myomas and pregnancy. Obstet Gynecol Clin N Am 1995; 22: 801-805.

  26. Beth W, Aydin A. Options for medical treatment of myomas. Obstet Gynecol Clin N Am 2006; 33: 97-113.

  27. Chwalisz K, DeManno D, Garg R et al. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata. Semin Reprod Med 2004; 22 (2): 113-119.

  28. Harkki-Siren P, Sjoberg J, Tiitinen A. Urinary tract injury alter hysterectomy. Obstet Gynecol 1998; 92: 113-118.

  29. Dubuisson, JB, Fauconnier, A, Deffarges, JV et al. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000; 15 (4): 869-873.

  30. Dubuisson JB, Fauconnier A, Fourchotte V et al. Laparoscopic myomectomy: Predicting the risk of conversion to an open procedure. Human Reprod 2001; 16: 1726-1731.

  31. Farquhar C, Vandekerckhove P, Watson A et al. Barrier agents for preventing adhesion after surgery for subfertility. Cochrane Data-base Syst Rev 2000.CD000475.

  32. Lasmar RB, Barrozo PR, Dias R et al. Submucous myomas: A new presurgical classification to evaluate the viability of hysteroscopic surgical treatment-preliminary report. J Minim Invasive Gynecol 2005; 12: 308-311.

  33. Indman PD. Hysteroscopic treatment of submucous myomas. Clin Obstet Gynecol 2006; 49 (4): 811-820.

  34. Milad MP, Sankpal RS. Laparoscopic approaches to uterine leiomyomas. Clin Obstet Gynecol 2001; 44 (2): 401-411.

  35. Istre O. Conservative treatment of fibroids. Gynecol Surg 2007; 4:73-78.

  36. Hutchins FL Jr. Worthington-Kirsch R. Embolotherapy for myoma-induced menorrhagia. Obstet Gynecol Clin N Am 2000; 27: 397-405.

  37. Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin No. 96. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008; 112: 387–400.




2020     |     www.medigraphic.com